Despite extensive research, disease heterogeneity within and between treatment-resistant patients is poorly characterized. Multiple myeloma (MM) is a neoplastic plasma-cell disorder characterized by clonal proliferation of malignant plasma cells. Nature Medicine volume 27, pages 491–503 ( 2021) Cite this article Identification of resistance pathways and therapeutic targets in relapsed multiple myeloma patients through single-cell sequencing
0 kommentar(er)
